News AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in
Events Partner Content 3rd Lab Asset & Facility Management in Pharma Summit Maximize Your Asset Value & Optimize Your Facility
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
